Turkey is emerging as a hub for Uveitis treatment, with institutions like Dunyagoz Eye Hospital Istanbul Etiler, Hisar Hospital Intercontinental, and Associate Professor M. Derda Ozer DERDA SAGLIK HIZMETLERI offering procedures such as corticosteroid injections and immunosuppressive therapy. Dunyagoz Eye Hospital holds the International Health Tourism Authorization Certificate, and Hisar Hospital is accredited by the Joint Commission International (JCI).
The success rate for Uveitis treatment in Turkey is promising, with survival rates reaching up to 90%. Associate Professor M. Derda Ozer's clinic is accredited by TEMOS International Healthcare Accreditation. These institutions attract international patients from CIS countries, Europe, the Commonwealth, and the Arab League States, offering world-class eye care.
Poland excels in Uveitis treatment, with specialized clinics like The Holy Family High Specialty Hospital in Rzeszów, part of the GVM Care & Research network, offering advanced care. The hospital has expanded to include Neurology and Radiology, enhancing its ability to treat complex conditions. Recent advancements include corticosteroid implants, immunosuppressive therapy, biologic agents, and vitrectomy surgery, significantly improving treatment outcomes.
The success rate of Uveitis treatment in Poland reaches 87%. The Polish healthcare system, monitored by the Centrum Monitorowania Jakości w Ochronie Zdrowia, ensures high quality and patient safety standards, contributing to the success in treating Uveitis.